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ABSTRACT
Introduction: The World Health Organization (WHO) recommends household tuberculosis (TB) contact
investigation in low-income countries, but most contacts do not complete a full clinical and laboratory
evaluation.
Methods: We performed a randomised trial of home-based, SMS-facilitated, household TB contact
investigation in Kampala, Uganda. Community health workers (CHWs) visited homes of index patients
with pulmonary TB to screen household contacts for TB. Entire households were randomly allocated to
clinic (standard-of-care) or home (intervention) evaluation. In the intervention arm, CHWs offered HIV
testing to adults; collected sputum from symptomatic contacts and persons living with HIV (PLWHs) if
⩾5 years; and transported sputum for microbiologic testing. CHWs referred PLWHs, children <5 years,
and anyone unable to complete sputum testing to clinic. Sputum testing results and/or follow-up
instructions were returned by automated SMS texts. The primary outcome was completion of a full TB
evaluation within 14 days; secondary outcomes were TB and HIV diagnoses and treatments among
screened contacts.
Results: There were 471 contacts of 190 index patients allocated to the intervention and 448 contacts of
182 index patients allocated to the standard-of-care. CHWs identified 190/471 (40%) intervention and
213/448 (48%) standard-of-care contacts requiring TB evaluation. In the intervention arm, CHWs
obtained sputum from 35/91 (39%) of sputum-eligible contacts and SMSs were sent to 95/190 (50%).
Completion of TB evaluation in the intervention and standard-of-care arms at 14 days (14% versus 15%;
difference −1%, 95% CI −9% to 7%, p=0.81) and yields of confirmed TB (1.5% versus 1.1%, p=0.62) and
new HIV (2.0% versus 1.8%, p=0.90) diagnoses were similar.
Conclusions: Home-based, SMS-facilitated evaluation did not improve completion or yield of household
TB contact investigation, likely due to challenges delivering the intervention components.
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Introduction
The STOP TB Partnership has called for the elimination of tuberculosis (TB) by 2050, but approximately
3.6 million patients still go undiagnosed each year [1]. The majority of missing individuals with TB reside
in low-income communities and many do not seek care despite persistent symptoms [2]. To help reach
these individuals, the World Health Organization WHO) issued guidelines recommending household TB
contact investigation as routine public health practice in low- and middle-income countries [3]. The
results of large, cluster-randomised, controlled trials show that household contact investigation increases
TB diagnoses [4] and likely reduces TB transmission in the community [5] compared with passive
case-finding. Nevertheless, most available evidence [6] and policies [7] do not address how contact
investigation should be adapted for delivery in high-burden, low-income countries. There is an urgent
need for implementation research to inform guidelines and practice [8].
We and others have identified low rates of delivery and uptake of household contact investigation in
several high-burden countries where contact investigation has been introduced, with only about 25% of
household contacts completing household TB screening and 20–89% of eligible contacts failing to
complete TB evaluation [9, 10]. Major barriers to the acceptance and completion of contact investigation
include a lack of TB-specific knowledge; TB-related stigma; travel and opportunity costs to attend clinics;
and dissatisfaction with quality of clinic services [11, 12]. To address these barriers, we designed a
multicomponent implementation strategy to facilitate more effective and patient-centred delivery of
household TB contact investigation [12]. This strategy consisted of community health worker
(CHW)-initiated TB evaluation at home, including HIV testing and sputum collection, transportation of
sputum to clinics for TB testing, and communication of testing results and follow-up instructions to
contacts by automated SMS texts. Initiating testing in the household adds further complexity to contact
investigation, and the feasibility and effectiveness of such services is unknown. Therefore, we sought to
determine whether this strategy could increase the proportion of contacts completing TB evaluation and
receiving new TB diagnoses and treatments.
Methods
Study design and setting
We performed a pragmatic, prospective, household randomised trial of home-based, SMS-facilitated
household TB contact investigation in Kampala, Uganda (Pan-African Clinical Trials Registry
#201509000877140). The Uganda National TB and Leprosy Programme (NTLP) offers free TB evaluation
and treatment services in public sector primary care clinics, and in 2013 it introduced household TB
contact investigation as a routine public health service in Kampala. Working with a local nongovernmental
organisation, we hired experienced, local CHWs to deliver household contact investigation and treatment
support. We trained them to provide home sputum collection and HIV counselling and testing services in
accordance with Uganda National Guidelines [13, 14], and reimbursed their travel expenses.
Study population and recruitment
CHWs invited consecutive “index” patients diagnosed with TB at seven public sector primary care clinics
to allow a home visit for CHWs to screen household members for TB at home. Index patients of any age
with pulmonary TB bacteriologically confirmed by sputum smear microscopy or GeneXpert MTB/RIF
testing, and young children (i.e. <5 years of age) clinically diagnosed with pulmonary or extrapulmonary
TB were eligible. CHWs visited the homes of index patients and identified all household contacts, defined
as individuals sleeping under the same roof as the index patient for ⩾1 day or night within the previous
3 months. Exclusion criteria are described in the supplementary material.
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2Pulmonary, Critical Care and Sleep Medicine Section, Yale School of Medicine, New Haven CT, USA. 3Uganda
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Study procedures including randomisation
After obtaining written informed consent from participants or their guardians and assent from minors
aged 8–17 years, CHWs collected demographic and clinical information from index patients and contacts,
including answers to TB screening questions for contacts. CHWs recorded responses using a customised,
Open Source, survey application (CommCare, Dimagi, Cambridge, MA, USA) wirelessly linked to a
Cloud-based server. An automated decision-support algorithm within the survey application based on
WHO contact investigation guidelines was used to identify contacts requiring additional clinical and/or
laboratory evaluation for active TB, including those reporting at least one TB symptom (cough ⩾2 weeks,
fever, night sweats, or weight loss ⩾3 kg), young children <5 years of age, and persons living with HIV
(PLWHs) (figure S3) [3].
After all contacts had completed TB screening, household members underwent concealed, 1:1,
household-level, random allocation to referral for open-label TB and HIV testing in nearby clinics
(standard-of-care) or in their own homes, with sputum testing results and/or follow-up instructions provided
by automated SMS (intervention). Chest radiography is not available in public sector primary care clinics in
Uganda and was therefore excluded from the screening and testing algorithms [8]. Allocation was stratified
by index patient age (adults ⩾15 years, older children aged 5–14 years, young children aged ⩽5 years), HIV
status, and enrolling CHW. Additional details are available in the supplementary material.
Intervention characteristics
In the standard-of-care arm, CHWs referred contacts with indications for TB testing and/or clinical
evaluation to health facilities for standard sputum examination, HIV counselling and testing, and
evaluation by a clinician. In the intervention arm, CHWs first offered home HIV counselling and testing
to contacts aged ⩾15 years, as previously described [15, 16]. After providing standardised instructions to
contacts, CHWs then collected one or two expectorated sputum samples over 2 days from eligible adults
and children ⩾5 years. CHWs delivered sputum to clinic laboratories for serial smear microscopy and/or
single-sample Xpert MTB/RIF testing according to the availability of these tests at each clinic (see
Methods, Online Supplement). CHWs entered all clinical information and sputum testing results into the
survey application, which applied an algorithm to characterise each contact’s need for further evaluation
and treatment according to pre-specified categories (figure S3). Category-specific messages reporting
results and/or follow-up instructions were generated following a customised algorithm (CommCare
Messaging) (figure S4) and delivered by automated SMS to participants in their preferred language using a
telephone number verified during the household visit (see Online Supplement).
Measurements and outcomes
The primary outcome, completion of TB evaluation within 14 days of enrolment among contacts requiring
additional evaluation for TB, was determined in collaboration with internal and external stakeholders [17].
We defined completion according to WHO contact investigation guidelines, which recommend a complete
sputum examination by serial smear microscopy or Xpert, and/or a clinic visit for a clinician’s evaluation
for young children, PLWHs, and for contacts who did not complete sputum examination [3]. Secondary
outcomes included 1) TB diagnosis and treatment initiation and 2) HIV diagnosis and linkage to HIV
care. We assessed fidelity through process evaluation of implementation metrics in intervention-arm
contacts only, including the proportions of eligible contacts undergoing HIV testing, of eligible contacts
providing sputum, and of eligible contacts to whom SMS were sent, as previously reported [15, 18–20].
We examined time to completion of TB evaluation as a post hoc secondary outcome. We pre-specified
subgroup analyses for TB completion by age (<5 years, 5–14 years, ⩾15 years) and HIV status.
Sample size calculations and statistical analysis plan
We estimated that 387 household contacts per arm would provide 80% power with a Type I error of 0.05
to detect an increase of ⩾15% in the proportion of eligible contacts completing TB evaluation, assuming
10% completed evaluation in the standard-of-care arm and a design effect of 1.7. Additional details are
available in the Online Supplement.
We compared baseline demographic and clinical characteristics of index patients with TB and contacts
between allocation groups using the Chi-squared test for categorical variables and the rank-sum test for
continuous variables. All analyses were conducted by intention to treat, without regard to adherence to
intervention components. We assessed between-arm differences in completion of TB evaluation, the
primary outcome, using mixed-effects, logistic models with random intercepts to capture household
clustering and robust standard errors. Regression standardisation was used to estimate the marginal
probability of the primary outcome by study arm, based on parameter estimates from the logistic model.
This approach was also used to estimate treatment effects on detection of TB (clinically confirmed and/or
microbiologically confirmed) among all contacts screened, a standardised indicator of the yield of contact
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investigation [21]. We applied the same approach to estimate the yield of new HIV diagnoses among
contacts aged ⩾15. Finally, we plotted Kaplan–Meier curves for the time to completion of TB evaluation
by treatment arm.
Human subjects’ considerations
This study protocol was approved by the Makerere School of Medicine Research Ethics Committee, the
Uganda National Council for Science and Technology, and the Yale University Human Investigation
Committee.
Results
Index patient enrolment
From July 2016 through July 2017, 14 CHWs screened consecutive index patients for eligibility (figure S1)
and enrolled 471 for household visits. Household visits were not completed for 99 (21%) patients, leaving
372 (80%) index patients whose households were visited.
Household contact enrolment
The 372 index patients reported 1228 household members living with them. During household visits,
CHWs screened 1193 (97%) household members for eligibility (figure 1). Of these, 274 (23%) did not
meet the eligibility criteria (figure S2), resulting in 919 (77%) enrolled contacts who were screened for TB
symptoms and risk factors. We stopped the trial upon exceeding the enrolment target.
Study population
Of 372 index patients whose households were visited, household contacts of 190 (51%) index patients were
randomised to the home-based, SMS-facilitated TB evaluation arm and household contacts of 182 (49%)
index patients to the standard-of-care arm. Demographic and clinical characteristics of index patients are
provided in table 1.
We enrolled 471 contacts in the intervention arm, and 448 contacts in the standard-of-care arm.
Demographic and clinical characteristics of contacts are provided in table 2. CHWs visited 22 (12%)
intervention-arm households and 26 (14%) standard-of-care arm households twice to enrol all contacts; all
other households were visited once. CHWs identified 190/471 (40%) intervention-arm contacts and
213/448 (48%) standard-of-care arm as patients eligible for further TB evaluation during screening. Most
contacts intended to follow-up in the same clinic where the index patient was recruited, whether in the
intervention (n=449, 95%) or standard-of-care (n=420, 94%) arm.
Assessed for eligibility from July 26, 2016 to July 11, 2017 (n=1193)
Randomised (n=919)
Excluded (n=274)
  Did not meet inclusion criteria (n=204)
  Declined to participate (n=69)
  Other reasons (n=1)
Allocated to intervention arm (n=471)
  Received allocated intervention (n=471)
Allocated to standard-of-care arm (n=448)
  Received allocated intervention (n=448)
Analysed for primary outcome (n=190)
  Excluded as no further TB evaluation indicated
    (n=281)
Analysed for primary outcome (n=213)
  Excluded as no further TB evaluation indicated 
    (n=235)
FIGURE 1 CONSORT flow diagram describing enrolment of household contacts. TB: tuberculosis.
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Fidelity of home-based procedures and SMS in the intervention arm
Among 255 intervention-arm contacts aged ⩾15 years, 229 were eligible for HIV counselling and testing.
Of these, 121 (53%) consented, all of whom were tested. Overall, 5 (4%) contacts were newly diagnosed
with HIV at home, 115 tested negative and 1 had an indeterminate test result and was referred to the
clinic for further testing. Sputum was obtained from 35/91 (39%) eligible contacts (i.e. contacts aged
⩾5 years who had TB symptoms or were PLWHs), with 28 (80%) tested with Xpert. SMSs were sent at
baseline as planned for 95/190 (50%) contacts undergoing TB evaluation; the other SMSs were never
initiated because of a programming error introduced during quality assurance testing in which a subset of
SMS targeting PLWHs were mistimed to the morning that evaluation status was updated (i.e. in the past)
rather than to the following morning.
Completion of TB evaluation
Summary results and subgroup analyses for primary and secondary outcomes are presented in table 3.
After adjusting for household clustering, contacts had a marginal probability of completing the TB
evaluation within 14 days of 14% (95% CI 8–20) in intervention households and 15% (95% CI 9–21) in
standard-of-care households (difference −1%, 95% CI −9% to 7%, p=0.81); the intra-class correlation was
TABLE 1 Characteristics of index patients with tuberculosis
Characteristics Intervention arm (n=190) Standard-of-care arm (n=182) p-value#
Age 0.44
<5 years 4 (2%) 7 (4%)
5–14 years 7 (4%) 4 (2%)
⩾15 years¶ 179 (94%) 171 (94%)
Female 80 (42%) 81 (45%) 0.64
HIV status+ 0.98
Positive 64 (34%) 63 (35%)
Negative 125 (66%) 118 (65%)
Unknown 1 (0.5%) 1 (0.6%)
Coughing time weeks 4 (3–12) 8 (3–12) 0.41§
Contacts reported 3 (1–4) 3 (2–4) 0.78§
Data are presented as median (interquartile range) unless otherwise stated. #: Chi-squared test of
significance unless otherwise stated; ¶: age among individuals ⩾15 years of age was 30 (24–38) years in
the intervention arm and 29 (24–38) years in the standard-of-care arm (p=0.94 by the Wilcoxon rank-sum
test of significance); +: HIV status was unknown for one patient in the intervention arm and for one patient
in the standard-of-care arm; §: Wilcoxon rank-sum test of significance.
TABLE 2 Characteristics of household contacts
Characteristics Intervention arm (n=471) Standard-of-care arm (n=448) p-value#
Age 0.29
<5 years 95 (20%) 106 (24%)
5–14 years 121 (26%) 121 (27%)
⩾15 years¶ 255 (54%) 221 (49%)
Female 293 (62%) 268 (60%) 0.46
HIV status prior to screening 0.15
Positive 27 (6%) 32 (7%)
Negative 308 (65%) 265 (59%)
Unknown 136 (29%) 151 (34%)
Any TB symptom present 106 (23%) 116 (26%) 0.23
Cough for ⩾2 weeks 70 (15%) 95 (21%) 0.01
Fever 32 (7%) 45 (10%) 0.08
Night sweats 28 (6%) 34 (8%) 0.32
Weight loss ⩾3 kg 37 (8%) 46 (10%) 0.20
TB: tuberculosis. #: Chi-squared test of significance utilised, unless otherwise noted; ¶: median
(interquartile range) age among individuals ⩾15 years of age was 26 (20–38) years in the intervention arm
and 27 (20–36) years in the standard-of-care arm (p=0.50 by the Wilcoxon rank-sum test of significance).
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0.66 (95% CI 0.40–0.85). At 60 days, marginal probabilities were 20% in the intervention arm and 18% in
the standard-of-care arm (difference 2.5%, 95% CI −6% to 11%, p=0.57). Figure 2 shows the cumulative
incidence of completing TB evaluation among eligible contacts stratified by allocation arm.
TB diagnoses
The proportion of all contacts diagnosed with microbiologically confirmed TB, also called the yield of
contact investigation, was similar in the intervention (7/471, 1.5%) and standard-of-care (5/448, 1.1%)
arms (OR 1.34, 95% CI 0.42–4.24, p=0.62). The marginal probability of contacts diagnosed with any form
TABLE 3 Study outcomes, adjusted for household clustering and stratified by clinically
relevant subgroups
Outcome# Intervention arm Standard-of-care arm p-value
Completion of TB evaluation
<5 years of age 8/95 (8%) 18/106 (17%) 0.12
5–14 years of age 11/32 (34%) 15/33 (45%) 0.41
⩾15 years of age without HIV 13/32 (41%) 9/45 (20%) 0.09
PLWH 5/32 (16%)¶ 4/32 (13%) 0.75
Yield of microbiologically confirmed TB
<5 years of age 2/95 (2.1%) 1/106 (0.9%) 0.51
5–14 years of age 3/121 (2.5%) 3/121 (2.5%) 1
⩾15 years of age without HIV 1/224 (0.5%) 1/192 (0.5%) 0.91
PLWH 1/32 (3.1%) 0/32 (0%) 0.31
Yield of clinically and microbiologically confirmed
TB
<5 years of age 5/95 (5.2%) 4/106 (3.8%) 0.62
5–14 years of age 3/121 (2.5%) 6/121 (5.0%) 0.38
⩾15 years of age without HIV 1/224 (0.5%) 5/192 (2.6%) 0.17
PLWH 1/32 (3.1%) 0/32 (0%)#
TB: tuberculosis; PLWH: person living with HIV. The denominator for completion includes only those
screening positive by symptoms, age or being a PLWH (190 in the intervention arm, 230 in the
standard-of-care arm). The denominator for yield outcomes includes all household contacts (471 in the
intervention arm, 443 in the standard-of-care arm). PLWHs are also reported with the relevant age
subgroups. #: assessed 60 days after contact enrolment; ¶: includes five PLWHs newly diagnosed during
home HIV counselling and testing.
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FIGURE 2 Cumulative incidence of eligible household contacts completing tuberculosis evaluation from the
time of enrolment, stratified by allocation arm.
https://doi.org/10.1183/23120541.00112-2019 6
TUBERCULOSIS | J.L. DAVIS ET AL.
of TB, including clinically diagnosed TB and extrapulmonary TB, were similar in the intervention (2.1%)
and standard-of-care (2.4%) arms (difference −0.2%, 95% CI −3% to 2%, p=0.83). All participants
diagnosed with TB (25/25, 100%) were initiated on TB treatment.
Subgroup analyses
Among contacts aged ⩾5 in the intervention arm, home sputum collection was substantially more
successful among contacts living without HIV (29/63, 46%) than among PLWHs (6/28, 21%, p=0.03). The
cluster-adjusted probability of completing TB evaluation within 60 days for symptomatic contacts aged ⩾5
without HIV was similar in the intervention arm (39%) and the standard-of-care arm (25%, difference
14%, 95% CI −4% to 31%, p=0.16).
Discussion
Active case-finding of undiagnosed individuals with TB in settings outside health facilities is a cornerstone
of the Global Strategy to End TB, which seeks to eliminate TB as a public health threat by 2050 [22].
Research evaluating bold, new, patient-centred strategies is critical to advancing toward these targets. In
this study, we carried out a rigorous evaluation of a novel patient-centred strategy to improve delivery and
completion of household TB contact investigation, a prototypical approach to active case-finding endorsed
by WHO [3]. In a real-world public health setting, only about one in five household eligible contacts
completed TB evaluation, and there was no improvement with home sputum collection and automated
SMS results reporting compared with TB evaluation in clinic.
Incomplete delivery of the intervention, including a low proportion of contacts successfully submitting
sputum and receiving SMS, may have contributed to its lack of effectiveness in improving completion of
TB evaluation by addressing previously documented distance and financial barriers to attending clinics
[12, 23]. As previously reported, contacts and CHWs reported several challenges with home sputum
collection, including difficulties for asymptomatic contacts in expectorating, limited private space to
expectorate indoors, and a reluctance to expectorate outside because of stigma [18]. Even symptomatic
contacts often failed to expectorate on the spot, and CHWs reported that leaving sputum containers to be
collected later was unsuccessful. CHWs sometimes did not carry enough sputum containers for all eligible
contacts. Although trained on safe sputum collection and transport [18] and equipped with particulate
respirators, CHWs expressed fears of contracting TB by collecting and carrying sputum in their work bags.
Finally, because intervention households were distributed among 17 CHWs, some CHWs only rarely
collected sputum, limiting the opportunities to gain proficiency. Low success rates of sputum collection
have been observed in other similar settings [9], including among PLWHs [24]. Future studies should
evaluate strategies to promote health worker confidence and competence in sputum collection, including
delivery of instructional videos via phones or tablet computers [25].
SMSs were successfully initiated for only half of intervention-arm contacts undergoing additional TB
evaluation. In a previous, more detailed process evaluation of SMSs, we found that <20% of SMSs achieved
their full effects, defined as being sent, delivered, read by the intended recipient, and having the message
content understood and retained [19]. Participants reported several barriers to engaging with SMS, including
sharing phones with friends and family; broken phones; an inability to read text messages; and a lack of
familiarity with or attentiveness to SMS. Although systematic reviews suggest that two-way SMS may be more
effective than one-way SMS [26], we also observed a low uptake of invitations to two-way SMS [19]. Previous
SMS interventions for TB in low- and middle-income countries have mostly used SMS longitudinally for
treatment support [27], rather than cross-sectionally to facilitate diagnostic evaluation as in this study,
although there is evidence suggesting that transaction-focused SMS such as appointment reminders modestly
increase clinic attendance in a variety of settings [28]. Participants in our study who confirmed receiving
SMS stated that while they found SMS helpful, it could not replace in-person disclosure of results [29].
This is among the first randomised trials of a mobile health intervention for TB in a low-income country.
As described previously, this intervention was developed with broad input from household contacts and
health workers [12, 17, 30] and deployed on a widely-used, Open Source mobile survey platform.
Nonetheless, we experienced substantial challenges adapting the application to the complexities of
household contact investigation, a multilevel intervention requiring a series of contingent steps occurring
at multiple times and locations. The logic required to generate automated SMSs was particularly complex,
encompassing thousands of unique clinical and laboratory states to determine if TB evaluation was
complete and send appropriate SMS content. This posed challenges for quality assurance testing that
slowed identification of programming errors, including one that prevented some SMSs from being sent.
WHO has called for increased high-quality research on digital interventions for TB care [31]. Given the
challenges with both patient engagement and delivery of digital interventions in this study [19, 32], there
is a need to involve professional designers to improve how patients and providers interface with mobile
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health interventions. User-centred design is an internationally accepted standard for quality in developing
information technology applications [33]. An evolution of this approach (termed “Human-Centred
Design” or generically, “design-thinking”) is increasingly being applied to build health delivery systems
that ensure participant engagement through methods that prioritise the needs of end-users throughout
intervention development [34, 35].
Our study had several limitations. First, we may not have captured all diagnoses of prevalent TB among
patients presenting to nonstudy (or study) clinics unbeknownst to CHWs; however, we believe
under-ascertainment of clinic visits is unlikely because the contacts’ clinic preferences mirrored those of
the index patients, and a prior audit found clinic registers and the survey application to be highly
concordant [10]. Second, although additional incident TB cases may be identified in the first 2 years after
household contact screening, we did not review clinic registers for incident clinic evaluations or diagnoses
of TB. We did however ask CHWs to record this information digitally, and they maintained close contact
with index patients as part of concurrent treatment support activities. Third, although household TB
contact investigation provides important opportunities for TB prevention through diagnosis and treatment
of latent TB infection, these services are not currently standard-of-care in Uganda.
Our study also had several strengths. This is among the first studies of a patient-centred strategy to
improve household contact investigation in a high-burden, low-income setting. As previously described
[12, 17], we employed a stakeholder-engaged approach informed by the Behaviour Change Wheel
framework and the Capability-Opportunity-Motivation-Behaviour theory to develop this implementation
strategy [36], and we evaluated it in a real-world setting using both implementation and effectiveness
metrics [37]. Although home-based, SMS-facilitated household contact investigation was no more effective
than the standard-of-care, clinic-based contact investigation, we carried out a careful process evaluation using
mixed methods to determine which components of the strategy did and did not work [15, 18, 20, 29].
As improving the quality of TB care assumes greater priority on the global TB research and programme
agenda [38, 39], such multilevel, multimodal evaluations are critical to understanding the context, fidelity,
and adaptability of new interventions.
Although fewer than one in five household contacts completed the TB evaluation across both study arms, the
yield of prevalent, microbiologically confirmed TB was 1%, similar to that reported in a recent randomised
trial in Vietnam [4]. This diagnostic yield was however lower than the 3.1–4.5% described in systematic
reviews [6, 40]. Future studies should examine whether the yield of new TB diagnoses can be improved by
reducing drop-out from each step of the contact investigation cascade, as demonstrated in clinic settings [41].
In addition, improving completion rates for TB evaluation increases opportunities for preventive treatment of
latent TB infection among close contacts, as envisioned by new WHO guidelines [42]. The suboptimal results
of implementation in this study highlight the many challenges of delivering complex, community-based
interventions like contact investigation in low-income countries, even when facilitated by mobile health
strategies. As the global community of TB practitioners and researchers continues its search for more effective
approaches for finding and treating undiagnosed individuals with TB and preventing TB among those who
have been exposed, there is critical need for research to address “know-do” gaps and equitably deliver
integrated services that are safe, timely, effective, patient-centred, efficient, and affordable.
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